CERO - CERO THERAPEUTICS HOLDINGS, INC.
0.0951
-1.695 -1,782.229%
Share volume: 45,096,838
Last Updated: 10-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.79
-1.69
-0.95%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-14-2024 | 11-20-2024 | 05-15-2025 | 11-19-2025 | |
| Cash flow financing | 0.000 | 0.000 | 6.322 M | 1.425 M | |
| Other financing cash flows | 0.000 | 0.000 | 716.876 K | -174.505 K | |
| Cash flow | 0.000 | 0.000 | 1.876 M | -1.281 M | |
| Net income | -2.449 M | -4.228 M | -5.106 M | -4.856 M | |
| Depreciation | 0.000 | 0.000 | 76.294 K | 69.354 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 500.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 0.000 | 0.000 | 2.271 M | -1.281 M |